Inhibition of Orbivirus Replication by Aurintricarboxylic Acid

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid

14 Pág.

Saved in:

Bibliographic Details
Main Authors:	Alonso, Celia, Utrilla-Trigo, S., Calvo Pinilla, Eva María, Jiménez-Cabello, L., Ortego, Javier, Nogales, Aitor
Other Authors:	European Commission
Format:	artículo biblioteca
Language:	English
Published:	Multidisciplinary Digital Publishing Institute 2020-10-02
Subjects:	Orbivirus, Arbovirus, Bluetongue virus, African horse sickness virus, Aurintricarboxylic acid, Antiviral,
Online Access:	http://hdl.handle.net/10261/338236 http://dx.doi.org/10.13039/501100003329 http://dx.doi.org/10.13039/501100000780 https://api.elsevier.com/content/abstract/scopus_id/85091939868
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
by: van Rijn, Piet A., et al.

Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance
by: Jiménez-Cabello, L., et al.
Published: (2022-07-14)

A Review of Knowledge Gaps and Tools for Orbivirus Research
by: Drolet, B.S., et al.

Interferon α/β receptor knockout mice as a model to study bluetongue virus infection
by: Ortego, J., et al.
Published: (2014)

Experimental infection of small ruminants with bluetongue virus expressing Toggenburg Orbivirus proteins
by: van Rijn, Piet A., et al.

The combined expression of the nonstructural protein NS1 and the N-terminal half of NS2 (NS21-180) by ChAdOx1 and MVA confers protection against clinical disease in sheep upon bluetongue virus challenge
by: Utrilla-Trigo, S., et al.
Published: (2022)

Current and next-generation bleutongue vaccines : Requirements, strategies, and prospects for different field situations
by: Feenstra, Femke, et al.

Gegevensverzameling voor beoordeling insleeproutes van Afrikaanse paardenpest in Nederland. een kwalitatieve risicoanalyse
by: Hoek, C.A., et al.

Kostenberekening van een uitbraak met Afrikaanse paardenpest in Nederland
by: Mourits, M.C.M., et al.

Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus
by: Agüero, M., et al.
Published: (2008)

Orbiviruses in the Mediterranean basin updated epidemiological situation of bluetongue and new methods for the detection of BTV serotype 4
by: Rodríguez-Sánchez, B., et al.
Published: (2008)

Vector competence is strongly affected by a small deletion or point mutations in bluetongue virus
by: van Gennip, René G.P., et al.

Anticorpos contra o vírus da língua azul em rebanhos ovinos da microrregião de Juazeiro, Bahia.
by: SOUZA, T. S. de, et al.
Published: (2011-01-11)

Epidemiological analysis of the 2006 blue tongue virus serotype 8 epidemic in north-western Europe. Distribution and dynamics of vector species
by: Meiswinkel, R., et al.

African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform
by: van Rijn, Piet A., et al.

Non-structural protein NS3/NS3a is required for propagation of bluetongue virus in Culicoides sonorensis
by: Feenstra, Femke, et al.

Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara
by: Marín-López, A., et al.
Published: (2020-01-22)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
by: Calvo Pinilla, Eva María, et al.
Published: (2018)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
by: Durán-Ferrer, Manuel, et al.
Published: (2022-07-15)

Vaccination as a Strategy to Prevent Bluetongue Virus Vertical Transmission
by: Rojas, José Manuel, et al.
Published: (2021-11-22)

Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants
by: van Rijn, Piet A., et al.

Comparative inhibitory activity of the stilbenes resveratrol and oxyresveratrol on African swine fever virus replication
by: Galindo Barreales, Inmaculada, et al.
Published: (2011)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
by: Aksular, M., et al.
Published: (2018)

Frequência de anticorpos contra o vírus da língua azul em ovinos do Estado do Ceará, Brasil.
by: PINHEIRO, R. R., et al.
Published: (2013-10-31)

Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells
by: Schnettler, E., et al.

Rigid amphipathic fusion inhibitors demonstrate antiviral activity against African swine fever virus
by: Hakobyan, A., et al.
Published: (2018)

Culicoides bij paarden in Nederland
by: Sloet van Oldruitenborgh-Oosterbaan, M.M.

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
by: Alberca, Berta, et al.
Published: (2014-06-17)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
by: Calvo Pinilla, Eva María, et al.
Published: (2015)

Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation
by: Calvo Pinilla, Eva María, et al.
Published: (2014)

Inquérito epidemiológico para detecção de anticopos contra o vírus da língua azul e Brucella ovis em rebanhos ovinos da Microrregião de Juazeiro - Bahia.
by: SOUZA, T. S. de
Published: (2012-07-02)

Rekenen aan Afrikaanse paardenpest
by: de Koeijer, A.A.

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses
by: Lasala, Fátima, et al.
Published: (2021-02)

Rapid and sensitive detection of African horse sickness virus by real-time PCR
by: Fernández Pinero, Jovita, et al.
Published: (2009)

Aanzet tot een risk analysis m.b.t. introductie van bluetongue virus en West Nile virus in Nederland
by: Elbers, A.R.W., et al.

Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppression
by: Melzi, E., et al.
Published: (2016)

A novel live DNA tagging system for African swine fever virus shows that bisbenzimide Hoechst 33342 can effectively block its replication
by: Martín, Verónica, et al.
Published: (2024-10)

A spatiotemporal model to assess the introduction risk of African horse sickness by import of animals and vectors in France
by: Faverjon, C., et al.

Novel gel-based and real-time PCR assays for the improved detection of African horse sickness virus
by: Rodriguez-Sanchez, B., et al.
Published: (2008)

IFNAR(-/-) Mice Constitute a Suitable Animal Model for Epizootic Hemorrhagic Disease Virus Study and Vaccine Evaluation
by: Jiménez-Cabello, L., et al.
Published: (2024-05-27)

Resource Map